Mandate

Vinge advises Carnegie and Nordea in connection with the listing of Volati on Nasdaq Stockholm

November 17, 2016

Vinge advises Carnegie Investment Bank AB (publ) and Nordea Bank AB (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of the common shares and preference shares in Volati AB (publ) on Nasdaq Stockholm. The company has applied for the company’s shares to be admitted for trading and Nasdaq Stockholm has approved the company’s shares for listing subject to customary conditions. A prospectus is expected to be published on or around 18 November 2016 and first day of trading is expected to be on or around 30 November 2016.

Volati is an industrial group comprising 13 business units organised into three business areas: Trading, Industry and Consumer. Volati has some 40 operating companies in 15 countries, with Sweden accounting for the largest share of net sales. Acquisitions are central in Volati’s strategy and Volati primarily acquires companies with proven business models, leading market positions and strong cash flows at reasonable valuations, and develops these with an emphasis on long-term creation.   

Vinge’s team consists of Dain Hård Nevonen, Erik Sjöman and Sofie Bjärtun.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026